news.cision.com

The Engineering News Record (ENR) has ranked AFRY as #1 globally in Pulp & Paper among international engineering and design firms. In the overall sector specific categories, AFRY secures its positions as top international engineering company in the Industrial Processes as #4 and #8 Power.AFRY's devotion to delivering sustainable solutions for our clients is reflected in the Engineering News Record (ENR) ranking. In the 2023 edition of the Top 225 International Design Firms list, AFRY stands among the 20 largest engineering companies, maintaining its 18th overall position from the previous

Publication of Anora’s Financial Statement Release for January–December 2023 on 14 February 2024 and invitation to results presentation

Anora Group Plc Press release 24 January 2024 at 10:00 a.m. EET Publication of Anora’s Financial Statement Release for January–December 2023 on 14 February 2024 and invitation to results presentation Anora will publish its Financial Statement Release for January–December 2023 on Wednesday 14 February 2024 at around 8:30 am EET. CEO Jacek Pastuszka and CFO Sigmund Toth will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting and we recommend to join the event through the online option: Join meeting here

Nordea Economic Outlook: Past the peak

The prospects for the global economy are still relatively good, despite significant monetary policy tightening. Inflation has fallen sharply, and central banks will likely start cutting rates this year. This increases the chances of a soft landing, but uncertainty is high, says Helge Pedersen, Nordea Group Chief Economist. The Nordic economies are feeling the effects of higher interest rates and weaker global demand. Denmark and Sweden are already in a technical recession; Finland is likely to follow suit; and economic activity in Norway has flattened. The outlook should brighten in

Verbrugge International streamlines operations with advanced Terminal Operating Systems from Konecranes

Photo: Verbrugge International BV · First Benelux order for Konecranes terminal software solutions for containerized and non-containerized cargo operations Dutch Logistics Service Provider Verbrugge International BV has chosen software solutions from Konecranes to streamline operations across three of its locations in The Netherlands. The agreement includes Terminal Operating Systems (TOS) for non-containerized and containerized cargo operations, and was booked in November 2023. Implementation is planned for 2024 and 2025. Verbrugge chose Konecranes to simplify its port

Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2024 Annual General Meeting

Oriola Corporation Stock Exchange Release 24 January 2024 at 10:00 a.m. EET Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2024 Annual General Meeting Oriola’s Shareholders’ Nomination Board has presented its proposal to the 2024 Annual General Meeting concerning the composition of the Board of Directors as follows: · The number of members of the Board of Directors would be seven · The present members of the Board of Directors Nina Mähönen, Yrjö Närhinen, Ellinor Persdotter Nilsson, Harri Pärssinen

Invitation to Tobii Dynavox’s webcast following the 2023 year-end report

Wed, Jan 24, 2024 08:48 CET

Tobii Dynavox will publish the 2023 year-end report on February 8 at 7.30 a.m. CET. Following this report, at 9.00 a.m. CET, Tobii Dynavox will host a presentation for investors, analysts and media.   Tobii Dynavox’s President and CEO Fredrik Ruben and CFO Linda Tybring will present and comment on the report. The presentation will be held in English and can be viewed as a live webcast. After the main presentation, a Q&A session will follow where the participants are welcome to ask questions by using the online chat function. If you wish to ask questions verbally, contact CFO Linda

Loomis AB to publish full-year report on January 31, 2024

Loomis AB will publish the full-year report January-December 2023 on Wednesday January 31, at 7:30 a.m. (CET).Agenda 7.30 a.m. (CET) - Report release The report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released. 8:00 a.m. (CET) - Presentation slides available For presentation slides, go to www.loomis.com and choose “Financial presentation”. 10.00 a.m. (CET) – Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference at 9:00 a.m.

Renowned Gastroenterologist, Dr. Adam S. Cheifetz, Joins AegirBio’s Scientific Advisory Board

AegirBio AB announces the appointment of Dr. Adam S. Cheifetz to its Scientific Advisory Board.Dr. Cheifetz, Director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School, brings unparalleled expertise in the field of gastroenterology, particularly in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. "We are honoured to welcome Dr. Cheifetz to our Scientific Advisory Board. His extensive knowledge, ground-breaking research, and leadership in the field of

Himalaya Shipping Ltd. (HSHP) – Special General Meeting Results Notification

Himalaya Shipping Ltd. (the “Company”) advises that a Special General Meeting of the Company was held on January 23, 2024 at 10:00 local time, at the Registered Office of the Company, 2nd Floor, S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda. The following resolution was approved by the Company’s shareholders: “To reduce the Share Premium account of the Company from US$97,876,367.66 to US$0 by the transfer of US$97,876,367.66 of the Share Premium to the Company’s Contributed Surplus account, with effect from January 23[rd], 2024.” The Board of Directors

Transcom to offer high-end customer experience from India through the acquisition of VCosmos

Transcom, the global AI powered CX challenger, today signed a letter of intent to acquire VCosmos, a high-end CX solution provider in India. VCosmos serves clients across North America, Asia, and Europe through voice, email, chat, and social media channels in their customer experience centers in Gurgaon and Jaipur, and their rapidly growing work-at-home network. They employ 700 people and can rapidly scale both voice and non-voice multi-lingual and multi-channel CX services. “We’ve been excited by India for some time, as the country provides an unbeatable combination of a scalable and

Fazer Bakery’s tasty new products for the spring – many ways to enjoy wholegrain and cakes that are ready to serve after defrosting

At the end of January, delicious new flavours will take over shops across the country, when Fazer Bakery is launching a variety of fibre-rich and tasty breads. The novelty selection also includes gluten-free Reissumies, gorgeous Pullava buttery buns and mouth-watering cakes made from Fazer’s sweets Pätkis and Fazerina. The in-store bake-off units will have a new, cheesy snack.Fazer Puikula Kuiturikas Kaura (fibre-rich oat bread) 6 pcs 330 g The porridge that forms the basis of the bread dough gives the bread a soft and rich structure that feels fresh for several days. In addition to its

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseJanuary 24, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On January 23, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |96,232 |3.9647

Medivir to present at the Redeye Fight Cancer Day

Wed, Jan 24, 2024 08:15 CET

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day, today January 24, 2024. CEO Jens Lindberg will present the company and updated data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) at 15.20 CET. The presentation is live broadcasted and can be followed at the event page; https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2

Quarterly Report I 23/24

September 2023 – November 2023, Diamyd Medical AB (publ), Fiscal year 2023/2024Precision Medicine for Autoimmune Diabetes in Pivotal Phase 3Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com September 1, 2023 – November 30, 2023 · Operating income: MSEK 1.0 (1.0) · Net result: MSEK -32.8 (-33.0) · Result per share: SEK -0.4 (-0.4) · Cash flow from operating activities: MSEK -27.8 (-27.1) · Cash and short-term investments at November 30, 2023: MSEK 176.7 (130.9)

Invitation to a press and analyst conference in Stockholm for the presentation of Concentric’s Fourth Quarter 2023 results

Concentric's Interim Report for Q4 2023 (January-December 2023), will be published on the 7th of February 2024, at 08.00 CET. At 10.00 CET media, investors and analysts are invited to Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm, for a presentation of the report. There will also be an opportunity to participate via webcast/telephone conference. President & CEO Martin Kunz and CFO Marcus Whitehouse will host the presentation, which will be held in English and is followed by a Q&A-session. We look forward to your participation. Please see the below detailed information to

Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics

Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions Broomfield, CO, USA and Södertälje, Sweden – January 24, 2024 – Flagship Biosciences, a leader in spatial biology and biomarker analytics services, and Offspring Biosciences, an innovator in pre-clinical biomarker assay solutions, today announced a strategic partnership that aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development.The partnership allows both companies to

Handelsbanken’s year-end report for January – December 2023 will be presented Wednesday 7 February

Handelsbanken publishes its year-end report for January – December 2023, at 07:00 a.m. CET Wednesday, 7 February. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Michael Green will present the year-end report at 09:00 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts,

Equity Issuance

For Immediate Release 24 January 2024 ROGUE BARON PLC (“Rogue Baron” or “the Company”) Equity Issuance Rogue Baron PLC (AQSE: SHNJ), a leading company in the premium spirit sector, announces that it has issued 3,928,571 ordinary shares to certain consultants and creditors of the Company. Admission to Aquis Growth Market Application will be made for the 3,928,571 new ordinary shares to be admitted to trading on the Aquis Growth Market ("Admission"). It is expected that Admission of the new ordinary shares will become effective at 8.00 a.m. on or around 29 January 2024.

Storytel sharpens focus on profitability on the back of strong Q4 2023 earnings and upgrades mid-term financial targets - announces efficiency initiative and write-downs